Nestlé has since the end of 2014 initiated the launch of powder formula with
Lactobacillus reuteri Protectis for children above the age of one year. The
products will mainly be sold in emerging markets.
For several years, BioGaia and Nestlé have had a fruitful cooperation to develop
products with probiotics. The parties have, as previously announced, entered
into an agreement signed 30 May 2013 and giving Nestlé the exclusive rights to
use BioGaia's patented probiotic strain Lactobacillus reuteri Protectis in an
additional range of products. The new product, powder formula for children over
the age of one year, is the result of this agreement.
As scientific support for the new range of products are clinical studies, such
as Pedro Gutierrez’ study published in 2014 in Pediatrics showing that
Lactobacillus reuteri Protectis could prevent infections in children older than
one year.
“We are pleased and excited about this cooperation and look forward to working
with Nestlé with the launch of the new product with L. reuteri Protectis”, says
Peter Rothschild, President of BioGaia.
Latest press releases from BioGaia
2015-01-12 BioGaia signs exclusive agreement in Vietnam
2014-12-11 BioGaia product effective in constipated adults
2014-12-01 BioGaia invests in promising research company
BioGaia has published this information in accordance with the Swedish Securities
Market Act. The information was issued for publication on 10 February 2015, 3:30
pm CET.
For additional information please contact
Peter Rothschild, Chief Executive Officer, BioGaia: 46 8 555 293 00
BioGaia is a healthcare company that develops, markets and sells probiotic
products with documented health benefits. The products are primarily based on
the lactic acid bacterium Lactobacillus reuteri, which has probiotic, health
-enhancing effects. The class B share of the Parent Company BioGaia AB is quoted
on the Mid Cap list of the NASDAQ OMX Nordic Exchange Stockholm. www.biogaia.com
